Fact CheckerSign in

NCT07684664Not yet recruiting

Allurion Gastric Balloon PAS

A Single-Arm, Multi-Center, US-based Study to Obtain Data Regarding the Safety and Effectiveness of the Allurion Gastric Balloon System in the Post-Market Setting

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

The primary purpose of this study is to confirm the safety profile results for the Allurion Gastric Balloon System (AGBS).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
29 Jun 2026
Start date
15 Jul 2026
Primary completion date
19 Feb 2029
Lead sponsor
Allurion Technologies
Diseases
Obesity
NCT number
NCT07684664

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From 15 Jul 2026 to the primary completion date, 19 Feb 2029
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any conditions that, in the opinion of the Investigator, may render the patient unable to complete the study, or lead to compliance with study requirements, or that might confound study data.

Other

  • Contra-indications to intragastric balloon placement as outlined in Instructions for Use

Who the study is looking for

  • Age ≥22 years and ≤ 65 years of age
  • BMI ≥30 kg/m2 and ≤ 40 kg/m2
  • Have signed study specific Informed Consent Form
  • Willing to comply with study requirements, including follow-up visits
  • Documented negative pregnancy test in women of childbearing potential
  • Women of childbearing potential not intending to become pregnant for the duration of study participation. (Note: Women of childbearing potential must not be nursing at the time of treatment).
  • Fully ambulatory without any severe chronic orthopedic disease that requires reliance on crutches, walkers or a wheelchair that could preclude exercise during the study
  • At least one unsuccessful attempt at weight loss, such as self-administered, commercial, or medically supervised weight loss program attempted within the 24 months preceding enrollment

Age in the registry: 22 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.